Galina Velikova

Also affiliated with Leeds Teaching Hospitals NHS Trust, St James's University Hospital

MedicineEconomics, Econometrics and Finance

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 8 papers. Top paper: “International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium”.

International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium

The Lancet Oncology(2020)10.1016/s1470-2045(19)30790-9

N/A

0.863DataRank · unranked

315 citations

Madeline Pe, Amylou C. Dueck, Jeff A. Sloan, Ethan Basch, Melanie Calvert +30 more

SPIRIT-PRO Extension explanation and elaboration: guidelines for inclusion of patient-reported outcomes in protocols of clinical trials

BMJ Open(2021)10.1136/bmjopen-2020-045105

N/A

0.738DataRank · unranked

136 citations

Madeleine King, Rebecca Mercieca‐Bebber, Olalekan Lee Aiyegbusi, Derek Kyte, Anita Slade +41 more

Improving completion rates of patient-reported outcome measures in cancer clinical trials: Scoping review investigating the implications for trial designs

European Journal of Cancer(2024)10.1016/j.ejca.2024.114313

N/A

0.449DataRank · unranked

19 citations

Abigirl Machingura, Ahu Alanya, Emma Lidington, Galina Velikova, Hans-Henning Flechtner +18 more

Using Machine Learning to Predict Unplanned Hospital Utilization and Chemotherapy Management From Patient-Reported Outcome Measures

JCO Clinical Cancer Informatics(2024)10.1200/cci.23.00264

N/A

0.345DataRank · unranked

9 citations

Vania Dimitrova, Lorraine Warrington, Galina Velikova, Kate Absolom, Zuzanna Wójcik

Truth and dare: patients dare to tell the truth when using PROMs in clinical practice

Quality of Life Research(2024)10.1007/s11136-024-03772-3

N/A

0DataRank · unranked

7 citations

Michiel A. J. Luijten, Amanda L. Blackford, Kate Absolom, Ethan Basch, Marion A J van Rossum +5 more

SISAQOL-IMI consensus-based guidelines to design, analyse, interpret, and present patient-reported outcomes in cancer clinical trials

The Lancet Oncology(2025)10.1016/s1470-2045(25)00520-0

N/A

0DataRank · unranked

12 citations

Ragnhild Sørum Falk, Ahu Alanya, Michael Schlichting, Satrajit Roychoudhury, Vishal Bhatnagar +95 more

Reaching beyond maximum grade: progress and future directions for modernising the assessment and reporting of adverse events in haematological malignancies

The Lancet Haematology(2022)10.1016/s2352-3026(22)00045-x

N/A

0DataRank · unranked

24 citations

Lori M Minasian, Vishal Bhatnagar, Franco Cavalli, R Angelo De Claro, Amylou C Dueck +35 more

Patient reported outcome assessment must be inclusive and equitable

Nature Medicine(2022)10.1038/s41591-022-01781-8

N/A

0DataRank · unranked

150 citations

Samantha Cruz Rivera, Ameeta Retzer, Sarah Hughes, Lisa Campbell, Barbara Molony-Oates +17 more